115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolution of survival disparities among adolescents and young adults with AML in the US
    Meeting Abstract

    Feliciano, E. G.; Dee, E. C.; Wu, J. F.; Martinez, J.; Singh, A.; Shah, N.; Jain, U.
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes offrailty subgroups treated with teclistamab in the real-world: An International Myeloma Foundation study database analysis
    Meeting Abstract

    Mian, H.; Tan, C. R.; Asoori, S.; Popat, R.; Abdallah, N.; Chhabra, S.; Parrondo, R. D.; Pond, G. R.; Martin, T.; Durie, B. G. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A single cell atlas of follicular lymphoma across clinical stages defines tumor B cell archetypes, immune microenvironment heterogeneity and novel cell states associated with high-risk FL
    Meeting Abstract

    Sarrabay, A.; Baaklini, S.; Barthelemy, C.; Gil, L.; Beyou, A.; Dahbi, L.; Mossadegh-Keller, N.; Huber, C.; Navarro, J. M.; Salles, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • ELA026, a monoclonal antibody targeting signal regulatory protein-α/β1/γ, rapidly controls inflammation and improves 2-month survival in treatment-naïve malignancy-associated hemophagocytic lymphohistiocytosis
    Meeting Abstract

    Maiti, A.; Daver, N.; Johnson, W. T.; Goyal, G.; Broome, C. M.; Gohil, S.; Van Laar, J.; Jimenez, J. L.; McCall, D.; Lane, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of brexucabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukemia in patients aged 60 and above
    Meeting Abstract

    Muhsen, I.; Advani, A. S.; Roloff, G. W.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Grunwald, M. R.; Kota, V. K.; Boccucci, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases
    Meeting Abstract

    Le Rhun, E.; Nayak, L.; Fat, M. J. L.; Rudà, R.; Pentsova, E.; Forsyth, P.; O'Brien, B.; Preusser, M.; Kumthekar, P.; Brandsma, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes of patients with IDH1/2 mutated accelerated/blast-phase myeloproliferative neoplasms in the era of IDH inhibitors
    Meeting Abstract

    Goldberg, L. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • TroFuse-015: A phase III study of trophoblast antigen 2 (TROP2)—directed antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA)
    Meeting Abstract

    Shitara, K.; Wainberg, Z. A.; van Cutsem, E.; Janjigian, Y. Y.; Xu, R. H.; Oh, D. Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • 292P Avelumab + axitinib (A + Ax) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC): Subgroup analyses by age from the final analysis of the phase III JAVELIN Renal 101 trial
    Meeting Abstract

    Oya, M.; Motzer, R. J.; Choueiri, T. K.; Haanen, J. B. A. G.; Eto, M.; Uemura, H.; Venugopal, B.; Rini, B. I.; Miyake, H.; Albiges, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save